Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by BRISTOL MYERS SQUIBB

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
004056 New Drug Application Approval
005657 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
006799 New Drug Application Approval New manufacturer (S) Standard review drug
006904 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
008392 New Drug Application Approval New manufacturer (S) Standard review drug
009052 New Drug Application Approval New formulation (S) Standard review drug
009218 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
009357 New Drug Application Approval New manufacturer (S) Standard review drug
010347 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
011123 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
011359 New Drug Application Approval New manufacturer (S) Standard review drug
016118 New Drug Application Approval New formulation (S) Standard review drug
016119 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
016295 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
016727 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
016885 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
016911 New Drug Application Approval New manufacturer (S) Standard review drug
016979 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
017056 New Drug Application Approval
017907 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
017928 New Drug Application Approval New manufacturer (S) Standard review drug
018125 New Drug Application Approval New formulation (S) Standard review drug
018731 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
019890 New Drug Application Approval New formulation (S) Standard review drug
019898 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
019915 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020152 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020154 New Drug Application Approval New molecular entity (NME) (P*) Priority review drug*
020155 New Drug Application Approval New formulation (P*) Priority review drug*
020156 New Drug Application Approval New formulation (P*) Priority review drug*
020264 New Drug Application Approval New formulation (S*) Standard review drug* (V) Orphan drug
020286 New Drug Application Approval New combination (S) Standard review drug
020357 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020412 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020413 New Drug Application Approval New formulation (P) Priority review drug
020457 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
020906 New Drug Application Approval New formulation (S) Standard review drug
020972 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
021178 New Drug Application Approval New formulation; New combination (S) Standard review drug
021183 New Drug Application Approval New formulation (P) Priority review drug
021190 New Drug Application Approval New formulation (S) Standard review drug
021202 New Drug Application Approval New formulation (S) Standard review drug
021360 New Drug Application Approval New formulation (S) Standard review drug
021387 New Drug Application Approval New combination (S) Standard review drug
021453 New Drug Application Approval New formulation (S) Standard review drug
021460 New Drug Application Approval New combination (S) Standard review drug
021567 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
021797 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
021798 New Drug Application Approval New formulation (P) Priority review drug
021986 New Drug Application Approval New molecular entity (NME) (P) Priority review drug (V) Orphan drug
022072 New Drug Application Approval New indication (P) Priority review drug
050341 New Drug Application Approval
050443 New Drug Application Approval New molecular entity (NME)
050530 New Drug Application Approval New formulation (S) Standard review drug
050580 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
050619 New Drug Application Approval New formulation (S) Standard review drug
050632 New Drug Application Approval New formulation (S) Standard review drug
060365 Abbreviated New Drug Application Approval
061392 Abbreviated New Drug Application Approval
061605 Abbreviated New Drug Application Approval
061935 Abbreviated New Drug Application Approval
062908 Abbreviated New Drug Application Approval
062926 Abbreviated New Drug Application Approval
070867 Abbreviated New Drug Application Approval
071083 Abbreviated New Drug Application Approval
071084 Abbreviated New Drug Application Approval
071311 Abbreviated New Drug Application Approval
080860 Abbreviated New Drug Application Approval
081295 Abbreviated New Drug Application Approval
083176 Abbreviated New Drug Application Approval
083266 Abbreviated New Drug Application Approval
084499 Abbreviated New Drug Application Approval
084500 Abbreviated New Drug Application Approval
085020 Abbreviated New Drug Application Approval
085910 Abbreviated New Drug Application Approval
085911 Abbreviated New Drug Application Approval
086454 Abbreviated New Drug Application Approval
089887 Abbreviated New Drug Application Approval
125118 Biologic License Application Approval
125288 Biologic License Application Approval (V) Orphan drug
125377 Biologic License Application Approval (V) Orphan drug
125527 Biologic License Application Approval
125554 Biologic License Application Approval
202155 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
206352 New Drug Application Approval New formulation (P) Priority review drug
761035 Biologic License Application Approval (V) Orphan drug

Back to Companies who have applied for FDA Drug Approval


 

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.